Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 11/20 | 0.38 |
| ▸ | MAOA | P21397 | 3/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 5/20 | 0.38 |
| ▸ | CYP21A2 | P08686 | 5/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 5/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10345141 | 0.86 | NFE2L2 (0.35) | MAOBMAOACYP17A1CYP11B1 | |
| SCHEMBL8737347 | 0.82 | MAOB (0.34) | MAOBMAOA | |
| SCHEMBL9630903 | 0.82 | MAOB (0.34) | MAOBMAOA | |
| SCHEMBL9630908 | 0.82 | MAOB (0.34) | MAOBMAOA | |
| SCHEMBL9630897 | 0.82 | MAOB (0.34) | MAOBMAOA | |
| SCHEMBL8737349 | 0.82 | MAOB (0.34) | MAOBMAOA | |
| SCHEMBL15744237 | 0.81 | MAOB (0.31) | MAOBMAOA | |
| SCHEMBL16978484 | 0.80 | CYP17A1 (0.45) | MAOBMAOACYP17A1CYP21A2CYP11B1 | |
| SCHEMBL27935712 | 0.79 | MAOB (0.50) | MAOBMAOA | |
| SCHEMBL27904620 | 0.78 | MAOB (0.53) | MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9315727-B2 | Compound having fluorinated naphthalene structure and liquid crystal composition of the same | DIC Corporation (Tokyo) (JP) | 2016-04-19 | — | — | US | disclosed |
| US-20150259599-A1 | COMPOUND HAVING FLUORINATED NAPHTHALENE STRUCTURE AND LIQUID CRYSTAL COMPOSITION OF THE SAME | DIC CORPORATION (JP) | 2015-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150259599-A1 | COMPOUND HAVING FLUORINATED NAPHTHALENE STRUCTURE AND LIQUID CRYSTAL COMPOSITION OF THE SAME | TNK1, CTNND1, FLI1 | MAOB 2298/4885MAOA 2457/4885CYP17A1 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.